awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33754603-8C23987B-D38B-4CEC-8FA2-46693A9F9281
Q33754603-8C23987B-D38B-4CEC-8FA2-46693A9F9281
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33754603-8C23987B-D38B-4CEC-8FA2-46693A9F9281
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.
P2860
Q33754603-8C23987B-D38B-4CEC-8FA2-46693A9F9281
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33754603-8C23987B-D38B-4CEC-8FA2-46693A9F9281
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
59dd4d38b55fbc7ff2dcd52f233b69f521c5c28d
P2860
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.